key: cord-0269949-yxg88z73 authors: Wang, D.; Chukwu, A.; Mwanyika-Sando, M.; Abubakari, S. W.; Assefa, N.; Madzorera, I.; Hemler, E. C.; Ismail, A.; Lankoande, B.; Mapendo, F.; Millogo, O.; Workneh, F.; Azemraw, T.; Febir, L. G.; James, C.; Tinkasimile, A.; Asante, K. P.; Baernighausen, T.; Berhane, Y.; Killewo, J.; Oduola, A. M.; Sie, A.; Smith, E. R.; Soura, A. B.; Tajudeen, R.; Vuai, S.; Fawzi, W. W. title: Levels and determinants of COVID-19 vaccine hesitancy among sub-Saharan African adolescents date: 2022-05-21 journal: nan DOI: 10.1101/2022.05.18.22275274 sha: 8bcb20772c36ab91214b443e6941921edeebc502 doc_id: 269949 cord_uid: yxg88z73 COVID-19 vaccine hesitancy among adolescents poses a challenge to the global effort to control the pandemic. This multi-country survey aimed to assess the levels and determinants of COVID-19 vaccine hesitancy among adolescents in sub-Saharan Africa between July and December 2021. The survey was conducted using computer-assisted telephone interviewing among adolescents in five sub-Saharan African countries, Burkina Faso, Ethiopia, Ghana, Nigeria, and Tanzania. A rural area and an urban area were included in each country (except Ghana, which only had a rural area), with approximately 300 adolescents in each area and 2803 in total. Sociodemographic characteristics and perceptions and attitudes on COVID-19 vaccines were measured. Vaccine hesitancy was defined as definitely not getting vaccinated or being undecided on whether to get vaccinated if a COVID-19 vaccine were available. Log-binomial models were used to calculate the adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for associations between potential determinants and COVID-19 vaccine hesitancy. The percentage of COVID-19 vaccine hesitancy was 15% in rural Kersa, 24% in rural Ibadan, 31% in rural Nouna, 33% in urban Ouagadougou, 37% in urban Addis Ababa, 48% in rural Kintampo, 64% in urban Lagos, 76% in urban Dar es Salaam, and 88% in rural Dodoma. Perceived low necessity, concerns about vaccine safety, and concerns about vaccine effectiveness were the leading reasons for hesitancy. Healthcare workers, parents or family members, and schoolteachers had the greatest impacts on vaccine willingness. Perceived lack of safety (aPR: 3.61; 95% CI: 3.10, 4.22) and lack of effectiveness (aPR: 3.59; 95% CI: 3.09, 4.18) were associated with greater vaccine hesitancy. The levels of COVID-19 vaccine hesitancy among adolescents are alarmingly high across the five sub-Saharan African countries, especially in Tanzania. COVID-19 vaccination campaigns among sub-Saharan African adolescents should address their concerns and misconceptions about vaccine safety and effectiveness. 8 143 between the ages of 10 to 19 years residing in the household. The sampling frames and sampling 144 methods for Burkina Faso, Ethiopia, and Nigeria have been described in detail previously [45] . The Round 1 survey was conducted between July and November 2020, and the Round 2 158 survey was conducted between July and December 2021. For the Round 2 survey, all households 159 with adolescents aged 10 to 19 years that participated in the Round 1 survey were contacted . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 21, 2022. The most highly trusted sources of information on COVID-19 vaccines for adolescents were television, radio, or newspaper 302 (85% overall), medical professionals (83% overall), and governmental communications (74% overall) (S1 Table) . In conclusion, we show that COVID-19 vaccine hesitancy among adolescents is high 455 across the five sub-Saharan African countries, especially in Tanzania. COVID-19 vaccination . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 21, 2022. ; https://doi.org/10.1101/2022.05.18.22275274 doi: medRxiv preprint willingness to receive the COVID-19 vaccine, perceptions of the vaccine, self-193 reported determinants of their willingness to be vaccinated, and their trusted information sources The outcome for the associational analyses was COVID-19 vaccine hesitancy, defined as 198 a response of definitely not getting the COVID-19 vaccine or maybe, unsure, or undecided on 199 whether to get the COVID-19 vaccine if it were available now. We defined vaccine hesitancy as 200 a dichotomous outcome. The potential determinants included age, sex, country, rural residence, 201 currently receiving education, perceived safety of the COVID-19 vaccine among children and 202 adolescents, perceived effectiveness of the COVID-19 vaccine We used log-binomial models to calculate the prevalence ratios (PRs) and 95% Older age was associated with a lower prevalence of COVID-19 vaccine hesitancy 313 adolescents in Ghana were 55% more likely to have COVID-19 vaccine hesitancy (aPR: 1.55; 95% CI: 1.28, 1.86), adolescents in 314 Nigeria were 44% more likely to have COVID-19 vaccine hesitancy (aPR: 1.44; 95% CI: 1.23, 1.68), and adolescents in Tanzania 315 were 142% more likely to have COVID-19 vaccine hesitancy (aPR: 2.42; 95% CI: 2.11, 2.78) COVID-19 vaccines were very effective, adolescents who perceived COVID-19 vaccines to be somewhat effective, not very effective, 321 and not effective at all had 1.9 times We report that the vaccine willingness of over 15% of adolescents in all areas is affected 401 by the vaccine's country of origin, with COVID-19 vaccines developed in the United States the 402 most accepted Accordingly, perceived lack of safety and perceived lack of samples, including 44,260 individuals from the United States, Russia, and 10 LMICs 418 in Asia, Africa, and South America [31]. The survey found that vaccine acceptance in LMICs is 419 primarily driven by the desire for personal protection We find that adolescent boys have less COVID-19 vaccine hesitancy than adolescent 427 girls, consistent with existing evidence. Among Turkish adults, males had a higher probability of The strengths of this study are the inclusion of multiple countries and cities in sub Saharan Africa and the measurement of a wide array of potential determinants of COVID-19 across sub-Saharan Africa. Therefore, the results provide important insights into the 448 levels of determinants of COVID-19 vaccine hesitancy in sub-Saharan Africa. Another limitation 449 is that, due to the nature of phone-based interviews, the adolescents included in most areas were 450 those who resided in households with access to a mobile phone. Consequently, the sample might 451 underrepresent adolescents from under-resourced households Division of Viral Diseases Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: 480 A Systematic Review and Meta-analysis Coronavirus Disease 2019 and Vaccination of 482 Children and Adolescents: Prospects and Challenges COVID-19 multisystem 484 inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection The evolving 487 epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young 488 people Multisystem inflammatory syndrome in US children and adolescents Vaccinating Children against Covid-19 -The Lessons of Measles. The World Health Organization. Achieving 70% COVID-19 Immunization Coverage by Mid-497 Attitudes Toward COVID-19 Vaccines in Chinese Adolescents. Frontiers in medicine Immunogenicity, and Efficacy of 502 COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines (Basel) Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of 506 Adolescents -United States Vaccine hesitancy: Definition, scope and determinants Top ten global health threats for 2019: the WHO list Nnorom-Dike O. COVID-19 vaccine 513 rollout: will it affect the rates of vaccine hesitancy in Africa? Public health (London) Wake AD. The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: 519 "Vaccination Refusal Could Prolong the War of This Pandemic" -A Systematic Review. Risk 520 management and healthcare policy COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of 523 19. Wake AD. The Acceptance Rate Toward COVID-19 Vaccine in Africa: A Systematic 524 Review and Meta-analysis. Global pediatric health COVID-19 vaccination 526 intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 527 countries. Infectious diseases of poverty A global survey of 529 potential acceptance of a COVID-19 vaccine COVID-19 vaccine hesitancy 531 among youth. Human vaccines & immunotherapeutics.ahead-of-print(ahead-of-print Parent and Peer Norms are Unique Correlates of COVID Older 536 adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for 537 informing public health strategies To be or not to be vaccinated against COVID-19 -The adolescents' perspective -A mixed-540 methods study in Sweden COVID-542 19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 543 vaccination rollout in sub-Saharan Africa. Human vaccines & immunotherapeutics.ahead-of-544 print Sociodemographic factors associated 548 with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in 549 western Uganda Assessment of Vaccine Hesitancy to a COVID-19 Vaccine 551 in Cameroonian Adults and Its Global Implication. Vaccines (Basel) Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes 554 among Adults to Receive COVID-19 Vaccines in Ghana. Vaccines (Basel) COVID-19 556 vaccine acceptance and hesitancy in low-and middle-income countries When it is 559 available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in The Pan African medical journal Acceptance of a 562 COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers in public 563 health The relationship of Covid-19 vaccine attitude with 565 life satisfaction, religious attitude and Covid-19 avoidance in Turkey. Human vaccines & 566 immunotherapeutics Knowledge, attitude, and 568 practice toward COVID-19 vaccination in Kazakhstan: a cross-sectional study. Human vaccines & 569 immunotherapeutics Understanding COVID-19 vaccine 571 acceptance in Pakistan: an echo of previous immunizations or prospect of change? Expert 572 review of vaccines Acceptance and 574 attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan Abdulah DM. Prevalence and correlates of COVID-19 vaccine hesitancy in the general 580 public in Iraqi Kurdistan: A cross-sectional study Cross-sectional analysis of COVID-19 vaccine 584 intention, perceptions and hesitancy across Latin America and the Caribbean. Travel medicine 585 and infectious disease 587 attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: 588 a cross-sectional study What Indians Think of 590 the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic 591 analysis Investigation of the relationships between perceived 593 causes of COVID-19, attitudes towards vaccine and level of trust in information sources from 594 the perspective of Infodemic: the case of Turkey adolescents and Young people in Sub-Saharan Africa: opportunities 596 and challenges: UNFPA Design and 598 Field Methods of the ARISE Network COVID-19 Rapid Monitoring Survey. The American journal 599 of tropical medicine and hygiene Design and field methods of the ARISE Network Adolescent Health Study. Tropical Medicine & 602 International Health Dar Es Salaam health and demographic surveillance system (Dar es Salaam HDSS). International 605 Pandemic and Adolescents' Experience in Sub-Saharan Africa: A Cross-Country Study Using a 608 Telephone Survey. The American journal of tropical medicine and hygiene An ultra-brief screening scale for anxiety and 610 depression: the PHQ-4 A modified poisson regression approach to prospective studies with binary data Tanzania refuses COVID-19 vaccines. The Lancet Covid-19: Counting the cost of denial in Tanzania A global pandemic in the time of 620 viral memes: COVID-19 vaccine misinformation and disinformation on TikTok Affecting COVID-19 Vaccine Acceptance: An International Survey among Low-and Middle-624 Income Countries. Vaccines (Basel) Risk Perception and Risk-Taking 626 Behaviour during Adolescence: The Influence of Personality and Gender